Materials and Reagents

Talon HiTrap columns, 1 ml (GE Healthcare, catalog number: 28-9537-66 )
24-well crystallization plates, VDX Greased Plates (Hampton Research Corporation, catalog number: HR3-170 )
Cover slips, 22 mm, siliconized (Hampton Research Corporation, catalog number: HR3-233 )
Nylon hydrophilic membrane filters, 0.2 µm (Merck Millipore Corporation, catalog number: GNWP04700 )
Ultrafree centrifugal filters, 0.1 µm (Merck Millipore Corporation, catalog number: UFC30VV00 )
LB (Luria Bertani) agar plates
Escherichia coli (E. coli) BL21 Rosetta (DE3) (Merck Millipore Corporation, Novagen, catalog number: 70954 )
pGEX-6P1 vector (GE Healthcare, catalog number: 28-9546-48 )
pET-24b vector (Merck Millipore Corporation, catalog number: 69750-3 ), modified to include a sequence encoding a His₆-SUMO tag followed by a PreScission cleavage site
Ampicillin (Fisher Scientific, catalog number: BP1760-25 )
Kanamycin (Fisher Scientific, Durable, catalog number: BP906-5 )
Chloramphenicol (Fisher Scientific, Bioreagents, catalog number: BP904-100 )
Tryptone (Fisher Scientific, catalog number: BP1421-2 )
Yeast extract (Fisher Scientific, catalog number: BP1422-2 )
Glycerol (P212121, catalog number: RP-G22020-0.5 )
KH₂PO₄ (Fisher Scientific, catalog number: P386-500 )
K₂HPO₄ (Fisher Scientific, catalog number: LC200901 )
Glucose (American Bio, catalog number: AB00715 )
Lactose (Fisher Scientific, Durable, catalog number: L5-500 )
MgSO₄·7H₂O (Sigma-Aldrich, Fluka, catalog number: 63140 )
EDTA-free protease inhibitor cocktail tablets (Sigma-Aldrich, cOmplete^TM, catalog number: 5056489001 )
Deoxyribonuclease I from bovine pancreas (Sigma-Aldrich, catalog number: DN25-1 g )
HEPES (Fisher Scientific, Durable, catalog number: BP310500 )
Sodium chloride (NaCl) (Thermo Fisher Scientific, Durable, catalog number: S271-10 )
TCEP HCl (P212121, catalog number: SV-TCEP-25 g )
Imidazole (Thermo Fisher Scientific, ACROS Organics, catalog number: 301870010 )
Ni Sepharose 6 Fast Flow (GE Healthcare, catalog number: 17-5318-02 )
Glutathione Sepharose 4B (GE Healthcare, catalog number: 17-0756-05 )
PreScission protease (produced in house; for more information see Reference 3)
12% Mini Protean TGX precast gels (Bio-Rad Laboratories, catalog number: 456-1046 )
Coomassie Brilliant Blue R-250 (Bio-Rad Laboratories, catalog number: 161-0400 )
Acetic acid (Fisher Scientific, Durable, catalog number: A491-212 )
Ethanol, 190 proof (Fisher Scientific, Durable, catalog number: 04-355-226 )
Guanidine hydrochloride (Sigma-Aldrich, catalog number: 50950 )
Trisodium citrate dihydrate (Alfa Aesar, catalog number: 36439-A3 )
NiCl₂ hexahydrate (Alfa Aesar, catalog number: 43185 )
Polyethylene glycol 8000 (Sigma-Aldrich, catalog number: 89510 )
NaSCN (VWR International, catalog number: 10118-142 )
Polyethylene glycol 3350 (Sigma-Aldrich, catalog number: P3640 )
Note: Product P3640 has been discontinued.
Meso-erythritol (VWR International, catalog number: CAAAA15813-22 )
TB (Terrific broth) medium (see Recipes)
Lysis buffer (see Recipes)
Gel filtration buffer (see Recipes)

Equipment

Standard laboratory equipment
Spectrophotometer device (Thermo Fisher Scientific, NanoDrop^TM, model: 1000 ) or comparable UV/VIS spectrophotometer
Note: This product has been discontinued by the manufacturer.
Microfluidizer cell disruptor (Microfluidics, model: 110S ) or comparable cell lysis equipment
Note: This product has been discontinued by the manufacturer.
Pumps (Bio-Rad Laboratories, model: EP-1 )
Note: This product has been discontinued by the manufacturer.
Chromatography system (Bio-Rad Laboratories, DuoFlow^TM, model: Medium-pressure ) or comparable chromatography system
Superdex 75 10/300 (GE Healthcare, catalog number: 17-5174-01 )
Stereo microscope (ZEISS, model: SteREO Discovery V8 ) or comparable microscope
Amicon Ultra-15 Centrifugal Filter Unit with Ultracel-50 membrane (Merck Millipore Corporation, catalog number: UFC905096 )
Ultrasonic bath (Fisher Scientific, model: FS60) or comparable sonication device
Note: This product has been discontinued by the manufacturer.

Procedure

Co-transform plasmids encoding HSV-1 UL31 (15-185) or PRV UL31 (1-176), in His6-SUMO-3C-pET24b, and HSV-1 UL34 (51-306) or PRV UL34 (18-271), in pGEX-6P1, into E. coli Rosetta cells using heat shock transformation. Plate on LB-agar plates containing 100 mg/L ampicillin, 50 mg/L kanamycin and 34 mg/L chloramphenicol.
Pick a single colony to inoculate a starter culture of 50 ml TB medium containing 1% glucose, 2 mM MgSO₄, 34 mg/L chloramphenicol, 100 mg/L ampicillin and 100 mg/L kanamycin. Incubate the culture in a shaker at 37 °C, 200 rpm, for 16 h.
Inoculate 3 L of TB containing 0.2% lactose, 2 mM MgSO₄, 100 mg/L ampicillin and 100 mg/L kanamycin with 10 ml of the starter culture and grow at 37 °C, 200 rpm, for 4 h. Reduce the temperature to 25 °C and grow the cultures for another 16 h. Typically a final OD₆₀₀ of 5-6 is reached.
Harvest cells by centrifugation at 5,000 x g for 30 min at 4 °C.
Filter and degas all buffers used in purification.
Throughout the purification, confirm the presence and quality of the purified proteins by SDS-PAGE analysis and Coomassie staining (Figure 1). Determine protein concentration by measuring the OD₂₈₀ [extinction coefficients: 37,360 M^-1 cm^-1 (HSV-1 NEC) and 34,840 M^-1 cm^-1 (PRV NEC)] using a spectrophotometer.
Wash cell pellets in lysis buffer and centrifuge in 50 ml conical tubes for 5 min at 5,000 x g at 4 °C. Discard the supernatant and process pellets immediately or flash freeze in liquid nitrogen and store at -80 °C.
Resuspend cell pellets in lysis buffer supplemented with the cOmplete Protease Inhibitor mix (one tablet/25 ml lysate) and DNase I (one tip of a spatula/50 ml lysate).
Lyse cells in a microfluidizer (3 runs, 80 psi). A comparable cell disruptor may be used instead.
Clear the cell lysate by centrifugation at 20,000 x g at 4 °C for 30 min. All subsequent steps are to be carried out at 4 °C or on ice.
Apply the supernatant onto a Ni-NTA sepharose column (8 ml), equilibrated with lysis buffer, with a flow rate of 2 ml/min and wash with lysis buffer containing 20-40 mM imidazole. Elute bound proteins with lysis buffer containing 250 mM imidazole.
Pass the eluted proteins over a GSH sepharose column (8 ml), equilibrated with lysis buffer, to remove excess His₆-SUMO-UL31. After washing with lysis buffer, use PreScission protease in a 1:30 molar ratio to cleave His₆-SUMO and GST tags on the GSH column for 16 h in one column volume lysis buffer circulating at a flow rate of 0.3 ml/min.
Apply lysis buffer to the GSH sepharose column and collect the flow-through fraction containing untagged NEC and His₆-SUMO. Apply this sample onto 2 tandem-coupled 1 ml Talon HiTrap columns to separate His₆-SUMO from the NEC. Collect the flow-through fraction, containing the untagged NEC, and concentrate it using a concentrator with a MWCO of 50 kDa.
Between different protein preparations, wash the Ni-NTA and GSH columns with one column volume 6 M guanidine hydrochloride and 0.2 M acetic acid. Then wash with 10 column volumes dH₂O.
To obtain monodisperse NEC, as a final purification step, apply the concentrated sample from step 13 to a Superdex 75 10/300 column equilibrated with gel filtration buffer.
Pool NEC-containing fractions from the monodisperse peak and concentrate up to ~10 mg/ml. Aliquot protein samples and flash freeze in liquid nitrogen for subsequent storage at -80 °C. The typical yield is 10 mg monodisperse NEC per L TB culture.
Prior to crystallization, dilute proteins to 5 mg/ml and filter through a 0.1 µm membrane to remove aggregates.
Grow HSV-1 NEC crystals by vapor diffusion in hanging drops with 0.5 µl protein and 0.5 µl reservoir solution in 10% PEG 8000, 0.1 M Na citrate, pH 5.6, 5 mM NiCl₂ at 22 °C. HSV-1 NEC crystals resembling hexagonal plates appear after 2 days and reach their final size after 1 week (Figure 2A).
Soak HSV-1 NEC crystals briefly in the reservoir solution containing 25% glycerol as a cryoprotectant and flash freeze in liquid nitrogen.
Grow PRV NEC crystals by vapor diffusion in hanging drops with 0.5 µl protein and 0.5 µl reservoir solution in 18% PEG 3350, 0.3 M NaSCN, 0.3 M NaCl at 22 °C. Tetragonal crystals of PRV NEC appear after one day and reach their final size after 2 days (Figure 2B).
Soak PRV NEC crystals briefly in the reservoir solution containing 15% meso-erythritol as a cryoprotectant and flash freeze in liquid nitrogen.

Representative data

Figure 1. 12% SDS-PAGE analysis of pure HSV-1 and PRV NEC

Figure 2. Crystals of HSV-1 NEC (A) and PRV NEC (B). Crystals were grown in hanging drops at 22 °C. The reservoir solution for growing HSV-1 NEC crystals contained 10% PEG 8000, 0.1 M Na citrate, pH 5.6, 5 mM NiCl₂, and for PRV NEC crystals 18% PEG 3350, 0.3 M NaSCN, 0.3 M NaCl.

Notes

Crystallization of HSV-1 NEC depends on the formation of a disulfide bond involving Cys278_UL31. Therefore, not more than 0.5 mM TCEP may be used during purification. Both protein complexes should be purified and frozen within 40 h to prevent degradation and aggregation.

Recipes

TB medium (per liter), autoclaved or filter-sterilized
12 gtryptone
24 g yeast extract
4 ml glycerol
0.231 g KH₂PO₄
1.254 g K₂HPO₄
Lysis buffer
50 mM HEPES, pH 7.0
500 mM NaCl
10% glycerol
0.5 mM TCEP
Gel filtration buffer
20 mM HEPES, pH 7.0
100 mM NaCl
0.5 mM TCEP

Acknowledgments

This work was funded by the NIH grants 1R21AI097573 and 1R01GM111795 (E.E.H.), the Burroughs Wellcome Fund (E.E.H.), and by the postdoctoral fellowship from the Deutsche Forschungsgemeinschaft GZ: BI 1658/1-1 (J.M.B.). Parts of this protocol were published previously in Bigalke et al., 2014 and Bigalke & Heldwein, 2015.

References

Bigalke, J. M., Heuser, T., Nicastro, D. and Heldwein, E. E. (2014). Membrane deformation and scission by the HSV-1 nuclear egress complex. Nat Commun 5: 4131.
Bigalke, J. M. and Heldwein, E. E. (2015). Structural basis of membrane budding by the nuclear egress complex of herpesviruses. EMBO J 34(23): 2921-2936.
Pitts, J. D., Klabis, J., Richards, A. L., Smith, G. A. and Heldwein, E. E. (2014). Crystal structure of the herpesvirus inner tegument protein UL37 supports its essential role in control of viral trafficking. J Virol 88(10): 5462-5473.